Skip to content

Jacquelyn Shaw, M.D.

NPI 1720187347ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Hasbrouck Heights, NJ

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Hasbrouck Heights, New Jersey, licensed in NJ, with an NPI issued in September 2006. Part D covered 52 prescriptions written in 2024, 94% of them generic. Ferring Pharmaceuticals Inc. reported $19.95 in payments in 2025, mostly food and beverage.

Overview

NPI1720187347
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedSep 21, 2006
Last updated in NPPESFeb 23, 2022
Certified by providerFeb 23, 2022

Specialties and licenses

TaxonomyCodeLicenseState
Obstetrics & Gynecology, Reproductive Endocrinology Primary207VE0102XMA55112NJ

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Obstetrics/Gynecology (NJ)

Part D prescriptions in 2024

Prescriptions (claims)52 · 68 30-day fills
Total drug cost$6,466
Generic share94% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$19.95 · 1 payment from 1 company
  • 2024$136.79 · 3 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$19.951

What the 2025 payments were for

  • Food and Beverage$19.95 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Hasbrouck Heights

All Obstetrics & Gynecology, Reproductive Endocrinology providers in New Jersey